Free Account Opening + AMC Free Demat
Loading...

Dolat Analysis and Research Reviewer Vs IPO Listing Gain

Check out Dolat Analysis and Research recommendations, such as subscribe, may apply, neutral, avoid and not rated for the various IPOs.

The recommendations will give you an idea of whether you should invest in that IPO or avoid it, and whether you should invest for the long term.

With the help of this report, you can analyse the difference between the issue price and the listing day price and see the gain and loss of a particular IPO.

In this report, you can also find the current market price and the 52 week high and 52 week low prices to analyse how a particular stock is performing.

Dolat Analysis and Research Reviewer Vs IPO Listing Gain

Issuer Company Issue Type Recommendation Listing Date Issue Size Subscribed Issue Price Listing Day Price Current Price 52 Week High 52 Week Low
Glenmark Life Sciences LimitedGlenmark Life Sciences Limited IPO detailGlenmark Life Sciences Limited Share Price, Chart and TipsMainlineApplyAug 06, 2021Rs 1513.60 Cr44.17xRs 720.00Rs 748.20 (3.92%)Rs 1,052.75 (46.22%)Rs 1,335.10 (Sep 16, 2024)Rs 611.20 (Oct 26, 2023)